Pharmacokinetic and pharmacodynamic properties of inhaled ciclesonide. - Wikidata - wikimedia - TriplyDB

Pharmacokinetic and pharmacodynamic properties of inhaled ciclesonide.

Pharmacokinetic and pharmacodynamic properties of inhaled ciclesonide.

http://www.wikidata.org/entity/Q36782563

about

Treating lung inflammation with agonists of the adenosine A2A receptor: promises, problems and potential solutions Management of proton pump inhibitor responsive-esophageal eosinophilia and eosinophilic esophagitis: controversies in treatment approaches Effectiveness and safety of ciclesonide in the treatment of patients with persistent allergic or non-allergic asthma in medical practice (Data from a non-interventional study conducted in Austria).Inhaled Corticosteroids Comparison of the efficacy of ciclesonide with that of budesonide in mild to moderate asthma patients after step-down therapy: a randomised parallel-group study.Ciclesonide and the treatment of asthma.Design and application of locally delivered agonists of the adenosine A(2A) receptor.Emerging drugs for eosinophilic esophagitis.The influence of sodium hyaluronate, L-leucine and sodium taurocholate on the nebulization of aqueous betamethasone-17-valerate suspensions.A geometrical approach to the PKPD modelling of inhaled bronchodilators.Sex Differences in the Effects of Inhaled Corticosteroids on Weight Gain among Patients with Asthma

P2860

Q24644038-8EED06ED-ECAA-43B4-B5A0-A12ADEC2E663 Q28080583-D653525C-9483-4EF4-A992-90D13227ADD2 Q30842735-6C740602-9391-40ED-8BB8-6F09661CC9FE Q33664193-6775A5A3-3A66-43D7-986A-2209448575F1 Q35216003-8D6C6808-98CB-45F0-AB31-6200A353C865 Q37681579-8E964C20-DF76-46FA-AE69-038D2F152BB4 Q37960072-639F33C6-32B4-4418-B6B0-29E1D1825E31 Q38128368-7F134113-6C92-4197-BF52-BB3721C840A7 Q41471780-3424E1F7-6444-481F-BC3A-3C5A7F6D012C Q47378899-054010A0-0ABC-4ED5-8914-9329465C6D61 Q58689843-67F00BA9-ECEA-408E-9F86-3B31AD309D75

P2860

Pharmacokinetic and pharmacodynamic properties of inhaled ciclesonide.

http://www.wikidata.org/entity/Q36782563

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Pharmacokinetic and pharmacodynamic properties of inhaled ciclesonide.

@en

type

label

Pharmacokinetic and pharmacodynamic properties of inhaled ciclesonide.

@en

prefLabel

Pharmacokinetic and pharmacodynamic properties of inhaled ciclesonide.

@en

P1433

Q36782563-E5B86AAA-FE4A-4E49-B7D3-A67039813FA5

P1476

Q36782563-4D691005-732E-49A9-B984-B619BB20745E

P2093

Q36782563-2A405204-3349-4CC5-80D8-232D09EFBC07

P2860

Q36782563-14EB47E4-C4AB-4F25-9E4C-0FEBBC2D12A2

Q36782563-1FA7CCEB-FCA6-4C44-8AEE-EFE1539EF87A

Q36782563-1FCFA54D-6756-45EA-AB3B-FCB6322F6FEA

Q36782563-20D62DA7-BA7A-44D3-AD22-B77BA2BB8423

Q36782563-23CDCAA3-6FEA-4A5B-9418-CA67E55ECB99

Q36782563-268806FA-0EDD-4588-AF77-A8D1202EF825

Q36782563-36DBD041-71FB-4D9D-9213-A903168834DA

Q36782563-3C191070-A988-4693-AD50-57E4FD4AA528

Q36782563-413B01E7-A293-4B96-8457-650D538194FC

Q36782563-437CC198-6549-46D9-AAB8-93903B510C05

P304

Q36782563-D8CC1EA2-A0EC-49D9-864A-697E33ABC5DA

P31

Q36782563-CBBC356A-231A-4652-AC6A-19A9E9205502

P356

Q36782563-14103010-87F5-4045-918A-353C3D03CBBF

P433

Q36782563-41438DB5-9147-4CFD-BAF8-296AC3201218

P478

Q36782563-78ECB05F-0525-4E46-8120-B25848988FCD

P577

Q36782563-973DC23A-C337-49E6-BF95-BC2D4855E688

P5875

Q36782563-8130FD48-D8AE-46C5-9953-77D8D22456B3

P698

Q36782563-941D2B98-4D43-47D7-B13B-8C49C6AF8F3B

P356

0091270007299763

P1433

The Journal of Clinical Pharmacology

P1476

Pharmacokinetic and pharmacodynamic properties of inhaled ciclesonide.

@en

P2093

Hartmut Derendorf

http://www.w3.org/2001/XMLSchema#string

P2860

Ultrafine particle deposition in subjects with asthma

The role of esterases in the metabolism of ciclesonide to desisobutyryl-ciclesonide in human tissue

Budesonide fatty-acid esterification: a novel mechanism prolonging binding to airway tissue. Review of available data.

Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review

Comparative physicochemical and pharmacokinetic profiles of inhaled beclomethasone dipropionate and budesonide.

Measures of hypothalamic-pituitary-adrenal function in patients with asthma treated with inhaled glucocorticoids: clinical and research implications.

Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma.

Systemic side effects of inhaled corticosteroids in patients with asthma.

Potential adverse effects of the inhaled corticosteroids.

Inhaled corticosteroids: past lessons and future issues.

P304

782-789

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0091270007299763

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P577

2007-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6408940

http://www.w3.org/2001/XMLSchema#string

P698

17412829

http://www.w3.org/2001/XMLSchema#string